ALB and metabolic dysfunction-associated steatotic liver disease: Our results are consistent and reproduce previous findings, where metabolic comorbidities, decline in serum albumin concentration and serologic non-invasive tests have proven to predict clinical events in people with cACLD due to NAFLD.[30], [31], [32]